CAS 905-96-4|3,3'-Diethyloxacarbocyanine iodide
| Common Name | 3,3'-Diethyloxacarbocyanine iodide | ||
|---|---|---|---|
| CAS Number | 905-96-4 | Molecular Weight | 460.31 |
| Density | / | Boiling Point | / |
| Molecular Formula | C21H21IN2O2 | Melting Point | 278ºC (dec.)(lit.) |
| MSDS | ChineseUSA | Flash Point | / |
Names
| Name | C3-oxacyanine |
|---|---|
| Synonym | More Synonyms |
3,3'-Diethyloxacarbocyanine iodide BiologicalActivity
| Description | 3,3'-Diethyloxacarbocyanine iodide is a microviscosity probe for micelles and microemulsions[1]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. SaswatiBasu, et al. 3,3′-Diethyloxacarbocyanine iodide: A new microviscosity probe for micelles and microemulsions. Colloids and Surfaces A: Physicochemical and Engineering Aspects. [2]. E L Sievers, et al. Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. 1999 Jun 1;93(11):3678-84. |
Chemical & Physical Properties
| Melting Point | 278ºC (dec.)(lit.) |
|---|---|
| Molecular Formula | C21H21IN2O2 |
| Molecular Weight | 460.31 |
| Exact Mass | 460.06500 |
| PSA | 35.09000 |
| LogP | 1.08680 |
| InChIKey | FIZZUEJIOKEFFZ-UHFFFAOYSA-M |
| SMILES | CCN1C(=CC=Cc2oc3ccccc3[n+]2CC)Oc2ccccc21.[I-] |
Safety Information
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
Articles43
More Articles| TLR signaling modulates side effects of anticancer therapy in the small intestine. J. Immunol. 194(4) , 1983-95, (2015) Intestinal mucositis represents the most common complication of intensive chemotherapy, which has a severe adverse impact on quality of life of cancer patients. However, the precise pathophysiology re... | |
| Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model. Sci. Rep. 5 , 16887, (2015) Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington's disease (HD). Inhibiting mHtt aggregation reduces cell death in t... | |
| Structure-activity relationship of cyanine tau aggregation inhibitors. J. Med. Chem. 52 , 3539-47, (2009) A structure-activity relationship for symmetrical cyanine inhibitors of human tau aggregation was elaborated using a filter trap assay. Antagonist activity depended on cyanine heterocycle, polymethine... |
Synonyms
| G 1745 |
| MFCD00011952 |
| DOC Iodide |
| (2Z)-3-ethyl-2-[(E)-3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole,iodide |
| 3,3'-dietyl oxacarbocyanine iodide |
| EINECS 212-996-6 |
